Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
NLSN Nielsen Holdings PLC
RBCAA Republic Bancorp Inc
IMTE Integrated Media Technology Ltd
GECC Great Elm Capital Corp
SCX L S Starrett Co
VFIAX Vanguard 500 Index Fund Admiral Shares
ONCT Oncternal Therapeutics Inc
BBRW Brewbilt Manufacturing Inc
AMOT Allied Motion Technologies Inc
Go

Health Care : Biotechnology | Mid Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Closing Price
$24.09
Day's Change
3.16 (15.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
24.99
Day's Low
20.75
Volume
(Light)
Volume:
62,338,250

10-day average volume:
92,436,837
62,338,250
  • Prev Close
    20.93
  • Today's Open
    21.00
  • Day's Range
    20.75-24.99
  • Avg Vol (10-day)
    92.4M
  • Last (time)
    4:00p ET 07/07/20
  • Last (size)
    5
  • 52-Wk Range
    1.92 - 33.79
    LowHigh
  • (10/02/19 - 06/26/20)
    28.71%
  • 155.1%
  • Market Cap
    3.8B
  • Shares Outstanding
    158.1M
  • -1.17
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 26.17
  • (% of float 06/15/20)
    16.72

Latest News

July 07, 2020
9:31 am ET
PR Newswire
July 04, 2020
9:26 am ET
MarketWatch
July 01, 2020
3:18 pm ET
MarketWatch
10:47 am ET
MarketWatch
9:31 am ET
PR Newswire
June 30, 2020
2:30 pm ET
MarketWatch
12:41 pm ET
MarketWatch
8:12 am ET
MarketWatch
7:35 am ET
MarketWatch
7:35 am ET
MarketWatch
7:35 am ET
MarketWatch
7:34 am ET
MarketWatch
7:34 am ET
MarketWatch
7:30 am ET
PR Newswire
June 27, 2020
8:43 am ET
MarketWatch
June 26, 2020
12:21 pm ET
MarketWatch
9:31 am ET
PR Newswire
7:13 am ET
MarketWatch
7:13 am ET
MarketWatch
June 25, 2020
9:31 am ET
PR Newswire
8:00 am ET
PR Newswire
7:26 am ET
MarketWatch
June 24, 2020
9:31 am ET
PR Newswire
June 23, 2020
9:31 am ET
PR Newswire
8:55 am ET
PR Newswire
7:54 am ET
MarketWatch
7:51 am ET
Zacks
7:33 am ET
MarketWatch
7:32 am ET
MarketWatch
7:30 am ET
PR Newswire
June 22, 2020
9:31 am ET
PR Newswire
June 20, 2020
12:11 pm ET
MarketWatch
June 15, 2020
9:00 am ET
PR Newswire
June 11, 2020
9:31 am ET
PR Newswire
June 04, 2020
6:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.